G. Delgado

发表

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection

C. Aceves, Yunuen Alfaro, G. Delgado, 2013, Molecular Cancer.

Uptake and gene expression with antitumoral doses of iodine in thyroid and mammary gland: evidence that chronic administration has no harmful effects.

G. Delgado, B. Anguiano, P. García-Solís, 2007, Thyroid : official journal of the American Thyroid Association.

Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line.

C. Aceves, G. Delgado, B. Anguiano, 2006, Endocrine-related cancer.

Is Iodine A Gatekeeper of the Integrity of the Mammary Gland?

C. Aceves, G. Delgado, B. Anguiano, 2005, Journal of Mammary Gland Biology and Neoplasia.

The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues.

C. Aceves, G. Delgado, B. Anguiano, 2013, Thyroid : official journal of the American Thyroid Association.

Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)

C. Aceves, G. Delgado, B. Anguiano, 2009, Molecular Cancer.

Antineoplastic effect of iodine and iodide in dimethylbenz[a]anthracene-induced mammary tumors: association between lactoperoxidase and estrogen-adduct production.

M. Gonsebatt, C. Aceves, G. Delgado, 2011, Endocrine-related cancer.

Total iodine quantification in fluids and tissues from iodine- or iodide-supplemented rats by ion chromatography following microwave-assisted digestion.

C. Aceves, G. Delgado, B. Anguiano, 2015, Thyroid : official journal of the American Thyroid Association.

Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects.

E. Rojas, C. Aceves, G. Delgado, 2008, Endocrine-related cancer.

Iodine Uptake and Prostate Cancer in the TRAMP Mouse Model

C. Aceves, G. Delgado, B. Anguiano, 2013, Molecular medicine.

Epididymis expresses the highest 5'-deiodinase activity in the male reproductive system: kinetic characterization, distribution, and hormonal regulation.

C. Aceves, G. Delgado, B. Anguiano, 2008, Endocrinology.

Deiodinase type 1 activity is expressed in the prostate of pubescent rats and is modulated by thyroid hormones, prolactin and sex hormones.

C. Aceves, G. Delgado, B. Anguiano, 2006, The Journal of endocrinology.

Has the mammary gland a protective mechanism against overexposure to triiodothyronine during the peripartum period? The prolactin pulse down-regulates mammary type I deiodinase responsiveness to norepinephrine.

C. Aceves, G. Delgado, B. Anguiano, 2004, The Journal of endocrinology.

Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I−) treatment Evidence that I2 prevents cancer promotion

R. Guzman, S. Nandi, M. Díaz-Muñoz, 2005, Molecular and Cellular Endocrinology.

Inhibition of intrathyroidal dehalog enation by iodide

H. Hernández-Montiel, A. Orozco, C. Valverde-R, 2010 .

Uptake and antitumoral effects of iodine and 6‐iodolactone in differentiated and undifferentiated human prostate cancer cell lines

C. Aceves, G. Delgado, B. Anguiano, 2013, The Prostate.

Inhibition of intrathyroidal dehalogenation by iodide.

H. Hernández-Montiel, A. Orozco, C. Valverde-R, 2011, The Journal of endocrinology.

Type 1 deiodinase activity and generation of triiodothyronine (T3) in prostate of sexually active rats

C. Aceves, A. Lopez‐Juarez, G. Delgado, 2009, The Prostate.

Uptake andAntitumoral Effects of Iodine and 6-Iodolactone inDifferentiatedandUndifferentiated HumanProstateCancerCell Lines

C. Aceves, G. Delgado, B. Anguiano, 2012 .